Disease Overview：Glaucoma（GLC）
Glaucoma is a group of progressive optic neuropathies characterized by irreversible retinal ganglion cell loss and subsequent visual field defects, often associated with elevated intraocular pressure (IOP). Primary open-angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) are the most prevalent forms; PACG is notably more common in East Asian populations. Without timely intervention, glaucoma leads to permanent vision impairment or blindness. Diagnosis relies on comprehensive ophthalmic evaluation—including tonometry, gonioscopy, optical coherence tomography (OCT) of the retinal nerve fiber layer, and automated perimetry—while management aims to achieve target IOP through pharmacotherapy, laser trabeculoplasty (e.g., selective laser trabeculoplasty), or surgical interventions such as trabeculectomy or minimally invasive glaucoma surgery (MIGS). Early detection and individualized, lifelong monitoring are critical, as disease progression is typically asymptomatic until advanced stages.
China offers distinct advantages for glaucoma care: its leading ophthalmology centers—many affiliated with top-tier universities—employ internationally trained specialists with extensive experience managing complex and refractory cases. Advanced diagnostic platforms, including spectral-domain OCT and ultra-widefield fundus imaging, are widely deployed. Clinical outcomes align with global benchmarks: studies from institutions like Beijing Tongren Hospital report >90% IOP control rates at 12 months post-MIGS, with low complication incidence. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising clinical rigor or regulatory compliance. As a dedicated medical tourism agency, we facilitate seamless access for international patients—vetting JCI-accredited hospitals, coordinating pre-arrival diagnostics, ensuring transparent, all-inclusive pricing, and providing end-to-end support from visa assistance to postoperative follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Glaucoma
Non-Surgical / Conservative Management
*Target criteria*: Early to moderate disease, intraocular pressure (IOP) ≤25 mmHg, stable visual field, no optic nerve progression over 6 months.
- •Topical Prostaglandin Analogues (e.g., latanoprost, travoprost):
- Annual medication cost: $216–$312
- •Beta-Blockers (e.g., timolol 0.5%):
- •Fixed-Dose Combinations (e.g., brimonidine/timolol):
- •Required Monitoring:
- Visual field test (Humphrey 24-2 SITA): $32 - OCT retinal nerve fiber layer scan: $48 - Comprehensive annual exam (including gonioscopy, fundus photography): $76
Surgical / Procedural Interventions
*Eligibility criteria*: Progressive optic neuropathy despite ≥3 medications, IOP >21 mmHg on maximal medical therapy, angle-closure anatomy, or advanced visual field loss.
- •Laser Trabeculoplasty (SLT):
- Preoperative workup (UBM, pachymetry, gonioscopy): $62
- •Trabeculectomy (with MMC):
- Preoperative: CBC, coagulation panel, ECG, chest X-ray: $84
- •Minimally Invasive Glaucoma Surgery (MIGS) — iStent inject® (2-stent):
- Preoperative: Same as trabeculectomy: $84
- •Tube Shunt Implantation (Ahmed/Ex-PRESS):
- Preoperative: Extended cardiac evaluation (if age ≥65): $112
Special / Complex Condition Management
- •Acute Angle-Closure Crisis:
- •Neovascular Glaucoma:
- •Pediatric Congenital Glaucoma:
Quick Selection Guide
- •<45 years, mild IOP elevation, budget-conscious: Start with prostaglandin monotherapy ($216/yr) + biannual monitoring ($152/yr)
- •60–75 years, moderate progression, comorbid hypertension/diabetes: SLT ($270) + timolol backup — avoids systemic drug interactions
- •≥75 years, advanced field loss, frailty: MIGS ($2,100) preferred over trabeculectomy due to lower complication risk and faster recovery
- •Uncontrolled neovascular or post-traumatic glaucoma: Tube shunt ($3,200+) is first-line; anti-VEGF adjunct adds $620/injection
- •Acute presentation with IOP >50 mmHg: Immediate iridotomy ($420) — delays irreversible optic nerve infarction
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Glaucoma Medical Vacation Packages
Curated transparent all-inclusive packages combining Glaucoma treatment with China top medical destinations:
